2025 Board of Directors
As the governing body, the ACAAM Board of Directors is comprised of individuals who are responsible for the ultimate direction of the management of ACAAM's affairs.
Executive Committee
Alexander Y. Walley, MD MSc
PRESIDENT
Dr. Walley is Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, primary care physician and addiction medicine specialist at Boston Medical Center focused on the medical complications of substance use, specifically HIV and overdose. He has led research studies on overdose and the integration of addiction specialty care and general medical care. He is the founder of the inpatient addiction medicine consult service and low barrier walk-in substance use care clinic at Boston Medical Center. Dr. Walley was the founding director of the Grayken Addiction Medicine Fellowship. He serves as the medical director for the Massachusetts Department of Health's Bureau of Substance Addiction Services and the Overdose Prevention Program.
Randall Brown, MD PhD
PRESIDENT - Elect
Dr. Brown is Associate Professor at The University of Wisconsin Department of Family Medicine and Community Health. Dr. Brown’s primary interests revolve around the treatment and prevention of substance use disorders and their complications in settings outside of the specialist treatment environment (such as primary care, hospitals, pharmacies, and criminal justice settings). He is Board Certified in Family Medicine and in Addiction Medicine. Dr. Brown's current research includes investigations in opioid misuse prevention, mobile technology to support recovery, promotion of medication prescribing for alcohol use disorders in primary care, and potential therapeutic applications of psilocybin and MDMA. He serves as a consulting physician in addiction medicine at two Madison hospitals, the UW HIV Clinic, and at Access Community Health Centers. Dr. Brown is also the Founding Director of the UW Addiction Medicine Fellowship Program, the Director of the UW fourth year Clinical Addiction Elective, and the Medical Director of the Overdose Prevention Program of the AIDS Resource Center of Wisconsin.
Jeanette M. Tetrault, MD FACP FASAM
IMMEDIATE PAST PRESIDENT
Dr. Tetrault is Professor of Medicine and Public Health, Vice-Chair for Education for the Section of General Internal Medicine, Associate Director for the Program in Addiction Medicine, and Fellowship Director for Addiction Medicine at Yale School of Medicine. Dr. Tetrault is the co-director of the Addiction Recovery Clinic at the New Haven Primary Care Consortium and a staff physician at the Central Medical Unit which is an integrated addiction and primary care clinic at the APT Foundation. Her work focuses on epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmacotherapies, and addiction medicine curriculum design, evaluation, and dissemination. She has been recognized for her teaching accomplishments being awarded the New England Regional Society of General Internal Medicine (SGIM) Clinician Educator of the Year Award in 2013, The W. Anderson Spickard Award for Excellence in Mentorship by the Association of Multidisciplinary Education and Research in Substance use and Addiction (AMSERSA) in 2018, and the American Society of Addiction Medicine Training Directors Award in 2021. In 2017, she was selected as a Macy Foundation Faculty Scholar.
J. Deanna Wilson, MD MPH
Treasurer
Dr. Wilson is Assistant Professor of Family Medicine and Community Health at the University of Pennsylvania. Dr. Wilson's research interests include reducing substance use-related health disparities and building equity, with an emphasis on innovative strategies to treat opioid use disorders in adolescent and adult populations. Her work includes integrating harm reduction into primary care settings, developing low threshold models of care to improve engagement and retention of vulnerable populations, and improving engagement and retention of adolescents and young adults in OUD treatment.
Valerie Carrejo, MD FAAFP
secretary
Dr. Carrejo practiced community-based healthcare at an FQHC for several years following residency. In 2010, she became board certified in addiction medicine, due to an expanding interest in treating patients with substance abuse. She joined the faculty at the UNM Department of Family and Community Medicine in fall 2012 to become more involved in education and further development in treating addictions in primary care, an ever-expanding need in New Mexico. In 2018, she developed the ACGME-accredited UNM Addiction Medicine fellowship, where she serves as the program director. She serves as a board member for the New Mexico Academy of Family Physicians (NMAFP) and the UNM School of Medicine Alumni Board. She still practices full-spectrum family medicine, including prenatal care, is Associate Professor, Medical Director of the UNM North Valley Center and Clinical Vice Chair for the Department of Family and Community Medicine.
Directors at Large
Julie M. Byler, DO
Dr. Byler is an Assistant Professor of Medicine at Oregon Health & Science University and led the expansion of IMPACT, an inpatient addiction medicine consult service, to Adventist Health Portland, an OHSU partner hospital. She is also the site director for the Inpatient Addiction Medicine Elective for OHSU medical students at Adventist Portland. Her areas of interest include the implementation of inpatient addiction medicine consult teams, inpatient management of alcohol withdrawal, substance use disorders in medical professionals, stigma, teaching, and curriculum design.
Christopher C. Holden, MD
Dr. Holden is Assistant Professor of Clinical Psychiatry at the University of Illinois College of Medicine. He serves as the Program Director of the Addiction Medicine Fellowship at the University of Illinois as well as the Director of Addiction of Addiction Psychiatry within the Department of Psychiatry, where he oversees the Recovery Clinic, an outpatient clinic that provides specialty care to patients with substance use disorders as well as substance use disorders that co-occur with mental illnesses. He also is the Medical Director of the Residential Addiction Treatment Program at the Jesse Brown VA Medical Center. Dr. Holden's research interests include pharmacotherapy for substance use disorders as well as chronic pain and the possible harms and benefits of long term opioid use.
Sharon Levy, MD MPH
Dr. Levy is a Developmental-Behavioral Pediatrician, Addiction Medicine specialist and Associate Professor at Harvard Medical School. She is the Director of the Adolescent Substance Use and Addiction Program at Boston Children’s Hospital, the past chair of the American Academy of Pediatrics Committee on Substance Use and Prevention, and the President of the Association for Medical Education and Research in Substance Abuse. Over the past 20 years she has evaluated and treated thousands of adolescents with substance use disorders, and she has written extensively on the topic. In 2016 she established the nation’s first accredited Pediatric Addiction Medicine Fellowship training program at Boston Children’s Hospital. She has conducted research to develop and test tools for identifying and addressing adolescent substance use disorders in general medical settings, and she has expertise in the integration of substance use treatment services into pediatric primary care.
Paula J. Lum, MD MPH
Dr. Lum is Professor of Clinical Medicine at the University of California, San Francisco (UCSF). She is also the Program Director of the UCSF Primary Care Addiction Medicine Fellowship and Past President of the Association for Multidisciplinary Education and Research in Substance use and Addiction. Board certified in internal medicine and addiction medicine, Dr. Lum practices and teaches at the intersections of HIV, addiction, and poverty. Her research and clinical activities for the last two decades have been grounded in evidence-based, patient-centered care that improves the health outcomes and life quality of the urban poor. Her academic interests include: (1) HIV and hepatitis prevention and treatment in persons who inject drugs, (2) innovations to address unhealthy substance use and its complications in primary care and non-traditional settings, and (3) curricular interventions to provide health care professionals with the skills, knowledge, and confidence to offer compassionate and effective care to persons who use drugs.
 Camille Robinson, MD MPH
Dr. Robinson is a public-health trained pediatrician, adolescent medicine specialist and addiction medicine specialist who provides primary care to adolescents and young adults at Annapolis Pediatrics in Maryland. She is an Adjunct Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine where she is involved with the medical education of trainees along the entire spectrum from medical school to fellowship. Her clinical and scholarly interests are substance use screening and treatment, trauma-informed care, and foster care medicine. Dr. Robinson graduated from the University of California, San Francisco School of Medicine. She completed her residency in pediatrics at Johns Hopkins as well as adolescent medicine fellowship and addiction medicine training at Johns Hopkins. She is board-certified in pediatrics, adolescent medicine, and addiction medicine.
A. Kenison Roy, III, MD (Ken)
Dr. Roy is Associate Professor of Psychiatry and Addiction Medicine at Tulane School of Medicine, Director of the Division of Addiction Medicine within the Department of Psychiatry, and Program Director of the Addiction Medicine Fellowship. He is a Distinguished Life Fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine. He is certified by the American Board of Psychiatry and Neurology, The American Board of Preventive Medicine in Addiction Medicine, and the American Board of Addiction Medicine. Dr. Roy is a member of the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, The American College of Psychiatrists, the American Medical Association, the Louisiana State Medical Society and the Louisiana Psychiatric Medical Association (LPMA) and is a Past President of LPMA. He has long held leadership positions in the American Society of Addiction Medicine (ASAM) and was most recently a member of the Board of Directors representing Region VII.
 Elizabeth A. Samuels, MD MPH MHS
Dr. Samuels is an emergency medicine physician, health services trained researcher, and Associate Professor of Emergency Medicine at the UCLA Department of Emergency Medicine. She completed her emergency medicine training at the Brown Emergency Medicine Residency Program, a health service research and health policy fellowship at the Yale National Clinician Scholars Program, and is board certified in Emergency Medicine and Addiction Medicine. Her work focuses on social emergency medicine and health equity initiatives, specifically community health worker/peer recovery programs, harm reduction services, low barrier substance use disorder treatment, care of transgender and gender nonbinary people, health care workforce diversity, and emergency department programs to address health related social needs.
Tricia Wright, MD MS
Dr. Wright is a Clinical Professor and Director of Maternal Mental Health and Addiction Medicine in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, where she combines her two passions, Obstetric Hospitalist and Addiction Medicine. She was previously at the University of Hawai‘i John A. Burns School of Medicine, where she founded and ran the Path Clinic, a perinatal clinic specializing in the care of pregnant individuals living with substance use disorders. She is a member of the American College of Obstetricians and Gynecologists Fetal Alcohol Syndrome Prevention Champions and Chair of ACOGs Opioid Use Disorder and Addiction Medicine Work Group. She is one of the founders and co-chairs of the Women’s Addiction Group for the American Society of Addiction Medicine. Her research interests include substance use disorders in pregnancy, including Screening, Brief Intervention and Referral to Treatment, optimal opioid dosing regimens in pregnancy, and the effects of substances including methamphetamine during pregnancy.
Past Presidents
|
